KRAEFTENS BEKAEMPELSE
Strandboulevarden 49 – Koebenhavn – 2100
VAT: DK55629013
http://www.cancer.dk
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, KRAEFTENS BEKAEMPELSE has received € 290,081.0 for its participation in a total of 1 project(s) with a total cost of € 3,583,870.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | 2018-11-30 | 642295 | MEL-PLEX | drug discovery · melanoma · simulation software · mathematical model | participant | € 290,081.88 | € 3,583,870 | 2 | 20 | CORDIS ↪ |
KRAEFTENS BEKAEMPELSE did not participate in complicit projects under Horizon Europe (2021-2027).
Within the FP7 (2007-2013) framework, KRAEFTENS BEKAEMPELSE has received € 470,000.0 for its participation in a total of 1 project(s) with a total cost of € 14,780,447.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2008-02-01 | 2012-01-31 | 200767 | APO-SYS | modeling of diseases spread | participant | € 470,000.0 | € 14,780,447 | 2 | 24 | CORDIS ↪ |